$BEAT HeartBeam — ALIGN-ACS pilot study results to be presented at TCT 2026 on Nov 1, 1:20 PM Pacific — Compares its credit card sized 3D ECG to a standard 12-lead ECG for detecting acute coronary syndrome, 132 ED chest pain patients at two sites in Belgrade, Serbia — Results will shape the planned U.S. pivotal study, expected to start Q1 2027 — Risk flag: no results released yet, heart attack use is still investigational and not FDA cleared Not financial advice.

$PODC PodcastOne — Got inbound acquisition interest from multiple strategic parties and is in talks with each — Board formed a special committee of independent directors and plans to hire an investment banker — Says the stock price undervalues it, #6 U.S. podcast publisher with 1B+ monthly impressions, $61.7M fiscal 2026 revenue — Risk flag: no offer named, no guarantee of a deal, parent LiveOne's debentures are secured by PodcastOne's assets Not financial advice.

$MWYN Marwynn Holdings — Signed a non-binding MOU with Grenada National Resort to evaluate a solar powered AI data center campus in Grenada — Planning scale about $500M across solar and data center, with a 24 month exclusivity window — Run through its NexaCore subsidiary, formed in April 2026 — Risk flag: no definitive agreement, the $500M is only a planning figure, no funding lined up, dilution possible Not financial advice.

$GPUS Hyperscale Data — Hired Newmark to find lenders for non-dilutive long-term debt on its Michigan AI data center campus — Initial 20 MW colocation deal with a California neocloud, 10 year term, option for another 32 MW — First 10 MW expected to be energized in December 2026, revenue starts then — Risk flag: hiring Newmark is not a loan commitment, no amount or terms yet, equity raise still possible Not financial advice.

$BURU Nuburu — Closed the 70% buy of Italian defense maker TEKNE on Oct 15, adds about 185 staff and three facilities — NYSE American compliance plan deadline is Oct 29, stockholders' equity was $10.13M as of June 30 vs the $4.0M threshold — About $96.8M of remaining order and program value at TEKNE, but it's preliminary and includes conditional items — Repaid about $16.75M of debenture and acquisition notes — Risk flag: NYSE American still decides on compliance, also got a warning letter on disclosure Oct 19 Not financial advice.

$ENVX Enovix — Declared a warrant dividend, 1 warrant for every 4 shares, record date Nov 13, distribution around Nov 18 — $3.00 strike, pay in cash or by handing in 2028 notes at face value, expires April 28, 2028 — Early expiration if the stock trades at $3.30 or higher on 20 of 30 trading days — Also bought back $100M of 2030 notes for about $63.1M, 37% below par — Risk flag: new shares if warrants are exercised, early expiration can shorten the window Not financial advice.

$MGN Megan Holdings — Priced a follow-on public offering of up to 15,000,000 Class A shares at $0.50, up to about $7.5M — Best efforts deal with no minimum, closing around Oct 29 — Malaysia-based shrimp farm builder, money goes to new products like its Smart Farming System, acquisitions and working capital — Risk flag: dilution, no minimum raise so the final size could be much smaller Not financial advice.

$KDK Kodiak AI — Signed a binding deal with DTL Transport to put the Kodiak Driver in 75 driverless trucks, first interstate carrier to commit to this in its own fleet — DTL pays a per-mile fee, runs I-10 Dallas to El Paso and I-20 Dallas to Atlanta — Driverless IKEA service on I-45 Dallas to Houston planned by year end — 35 driverless trucks already running for Atlas Energy, growing to 100 by mid-2027 — Risk flag: no dollar value or fee rate disclosed, rollout dates still ahead Not financial advice.

$AXTI AXT Inc — Announced up to RMB 3.67B (about $545M) in private equity financing for its China subsidiary Tongmei — Tongmei pulled its STAR Market IPO in July and plans a Hong Kong listing focused on indium phosphide — Earlier private equity investors hold redemption rights on about RMB 324M ($49M) — Risk flag: likely dilutes AXT's stake in Tongmei, investors, valuation and timing not in the headline Not financial advice.

$RUBI Rubico — 1-for-25 reverse split, trading split-adjusted at the open on Oct 30 — Shares drop from 13,517,355 to about 540,694 — Aimed at keeping its Nasdaq listing — Owns two Suezmax tankers, three MR tanker newbuildings due in 2029 — Risk flag: sister company TOP Ships also just raised money through convertible notes Not financial advice.

$AIOK 30% up now.

Today's PRs. — $SIGA SIGA Technologies: Up to $15M Canadian defence contract for TPOXX, $9M firm — $BKYI BIO-key: New Middle East government identity security deployment, no contract value given — $INMB INmune Bio: $4.5M registered direct offering, 3M shares plus warrants at $1.65 — $TNON Tenon Medical: First alpha cases done for Quickstep Decorticator, full release Q1 2027 — $REBN Reborn Coffee: Tri-party supply deal, $30M annual target, $2M order confirmed — $SLS SELLAS: Phase 3 REGAL hit the 80th event, topline results due this quarter — $ELPW Elong Power: One-year $25.5M cooperation deal, first $0.84M delivered — $GNPX Genprex: REQORSA research at GSA 2026, Nov 4-7 Not financial advice.

Today's PRs, penny stocks. — $TDTH Trident Digital Tech: CEO to buy up to 1M Class B shares in the open market, max $1.00, owns about 8.92% — $RCT RedCloud: Insiders buying 31.7M shares at $0.25, about $7.9M, paid by offsetting debt — $GERN Geron: Discontinued Phase 3 IMpactMF in myelofibrosis after the monitoring committee said the survival endpoint was unlikely — $NXXT NextNRG: 1-for-10 reverse split, split-adjusted trading Oct 30, authorized shares cut from 500M to 50M — $VBIO Valion Bio: Positive mouse safety data for Entolimod, next is a funded AFRRI efficacy study — $BENF Beneficient: Motion to cancel about $130M of HCLP debt tied to ex-CEO Heppner, seeks to recover $211M paid — $TOPS TOP Ships: $5.0M convertible notes and warrants placement, warrants for 19.8M shares at $0.28 Not financial advice. @TT_stocks_ @pmony5 @stockplaymaker1

$SLS SELLAS Life Sciences — Phase 3 REGAL trial of galinpepimut-S in AML reached the pre-specified 80th event, triggering the final analysis — Database lock and unblinding next, topline overall survival results expected this quarter — Trial tests GPS as maintenance therapy in patients in second complete remission — Risk flag: binary event, reaching 80 deaths says nothing about whether the drug worked Not financial advice.

$REBN Reborn Coffee — Upgraded its supply deal with Visvita into a tri-party framework with South Korean and Vietnamese OEM beverage makers — Targets $30M annual product supply, first $2M purchase order already confirmed and shipping — Products include Visvita's aloe vera drinks plus co-branded Matcha Latte and Milk Coffee for retail across the Americas — Risk flag: $30M is a target, not a firm commitment, final terms with manufacturers still being worked out Not financial advice.

$TNON Tenon Medical — Finished the first alpha cases of its Quickstep Decorticator for the SImmetry+ SI joint fusion system — One instrument drills and decorticates, with interchangeable blades in multiple sizes — Full market release targeted for Q1 2027, more product launches expected in coming quarters — Risk flag: only early alpha cases, feedback came from a paid consultant surgeon, no sales numbers given Not financial advice.

$TDTH Trident Digital Tech — CEO Soon Huat Lim plans to buy up to 1,000,000 Class B shares in the open market with his own money, at no more than $1.00 each — He owns about 8.92%, shares bought carry the same lock-up and leak-out terms as September investors — Expects about $14M revenue from Sikaflow in Ghana by year-end, IRMA launches in five markets in November — Risk flag: no minimum purchase required, can be changed or stopped anytime, revenue target not yet reported Not financial advice.

$GERN Geron — Discontinued the Phase 3 IMpactMF trial of imetelstat in relapsed or refractory myelofibrosis — Independent monitoring committee said it was unlikely to hit the overall survival primary endpoint — No new safety signals, trial had 327 patients — Plans to keep growing RYTELO sales in lower-risk MDS — Risk flag: myelofibrosis was a pipeline growth path, full data to come later Not financial advice.

$INMB INmune Bio — Priced a $4.50M registered direct offering, 3,000,000 shares at about $1.50 each — Concurrent private placement of warrants for 3,000,000 shares at $1.65, exercisable after six months, five and a half year term — Closing around Oct 29, money goes to working capital — Risk flag: dilution, small raise, warrants add more shares later Not financial advice.

$NXXT NextNRG — 1-for-10 reverse split, trading split-adjusted at the open on Oct 30 — Shares drop from about 16.84M to about 1.68M — Authorized shares cut from 500M to 50M, preferred stock authorization unchanged — Risk flag: reverse splits often come with follow-on dilution Not financial advice.